--- title: "Former Boston Beer CEO Martin Roper Sold $2.5M of Vita Coco After COCO's 52-Week Surge" type: news slug: martin-roper-boston-beer-ceo-vita-coco-exercise-sell-2026 canonical_url: https://13finsight.com/news/martin-roper-boston-beer-ceo-vita-coco-exercise-sell-2026 published_at: 2026-04-13T20:42:51.206Z updated_at: 2026-04-14T00:11:44.325Z author: Alex Rivera author_title: Breaking News Editor author_url: https://13finsight.com/authors/alex-rivera word_count: 788 locale: en source: 13F Insight --- # Former Boston Beer CEO Martin Roper Sold $2.5M of Vita Coco After COCO's 52-Week Surge > Martin Roper monetized 50,000 Vita Coco options for about $2.5 million in April, weeks after COCO hit a 52-week high and after the company posted 18% full-year sales growth. Martin Roper sold roughly $2.52 million of Vita Coco stock on April 7-8 after exercising 50,000 low-strike options at $10.178 per share. The timing matters because COCO had just come off a sharp post-earnings run that pushed the stock to a 52-week high in March, turning a routine compensation event into a well-timed liquidity move. One important correction to the raw insider-profile framing: Roper is not Boston Beer's current CEO. He ran Boston Beer from 2001 to 2018, while Vita Coco's investor-relations site lists him as the company's current CEO and Boston Beer said in August 2025 that founder Jim Koch returned to the CEO role. That makes this filing more relevant to COCO holders than to SAM holders, even though Roper's long Form 4 history still ties him closely to Boston Beer. Transaction breakdown DateCodeSecuritySharesPriceEstimated value 2026-04-07MCOCO25,000$10.178$254,450 exercise cost 2026-04-07SCOCO25,000$50.00$1,250,000 proceeds 2026-04-08MCOCO25,000$10.178$254,450 exercise cost 2026-04-08SCOCO25,000$50.949$1,273,725 proceeds Gross sale proceeds came to about $2.52 million, while the combined exercise cost was just under $509,000. In other words, Roper used a two-day window near $50 a share to crystallize roughly $2.01 million of intrinsic option value. Why this sale stands out now Vita Coco had given executives a strong tape to sell into. The company reported full-year 2025 net sales of $610 million on February 18, up 18% year over year, with Vita Coco Coconut Water sales up 26% for the full year. Management also guided for 2026 net sales of $680 million to $700 million and adjusted EBITDA of $122 million to $128 million, reinforcing the market's view that COCO is still one of the faster-growing names in beverages. That backdrop helps explain why an exercise-and-sell at about $50 does not read like distress selling. COCO had traded as high as $61.39 in March before pulling back into the high-$40s by early April, so Roper was still monetizing options at nearly five times the $10.178 strike price even after the stock cooled off. On the earnings call, management said a Walmart reset was adding 5% to 6% to total scans, another sign that the brand's distribution story was still working. The bigger picture is that public markets have recently rewarded growth beverage stories more than mature alcohol names. Investors watching SAM, TAP, and STZ have spent the last year debating category fatigue and mix shifts, while global drink giants like KO and PEP trade on scale and resilience. COCO sits in a different bucket: smaller, faster, and more sensitive to execution around distribution, pricing, and category momentum. Ownership context: what the filing says after the sale The April filing does not show a full exit. Form 4 Table I listed 298,484 common shares after the April 8 sale, and the derivative section still showed 529,670 securities remaining after the option exercise activity. That is why this should be read as monetization, not abandonment. Roper's broader insider record is unusually deep because his career spans multiple beverage and consumer boards, including MGP Ingredients. 13F Insight's profile logs 2,955 insider transactions and about $283.6 million of career sales, most of them tied to Boston Beer rather than Vita Coco. For Boston Beer itself, beneficial ownership remains concentrated even without Roper in management. The latest 13D/G filings show founder C. James Koch at 21.62%, Vanguard at 12.09%, and AQR Capital Management at 5.12% in SAM. That matters because Roper's name still carries Boston Beer SEO value, but the capital-markets signal in this filing is overwhelmingly about COCO. Key facts MetricValue InsiderMartin Roper Current operating roleChief Executive Officer of Vita Coco Boston Beer linkFormer CEO of Boston Beer from 2001 to 2018 Recent transaction patternTwo-day exercise-and-sell in COCO Shares sold50,000 Average sale priceAbout $50.47 Estimated gross proceedsAbout $2.52 million Exercise price$10.178 per share Common shares after latest sale298,484 per Form 4 Table I Derivative securities after latest exercise activity529,670 per Form 4 Table II Career insider transactions2,955 Career sales tracked by 13F Insight$283.6 million What to watch next COCO Q1 results in late April — management already told investors to expect the next update in late April, so the key question is whether scan momentum and private-label recovery are still supporting the $680 million to $700 million full-year sales target. COCO versus its March high — if shares reclaim the $61 area, future option exercises by Roper or other executives would look more like disciplined profit-taking than a warning sign. Remaining low-strike equity — the filing still showed substantial derivative exposure after this two-day sale, so investors should watch whether Roper keeps using strength to reduce that overhang in measured pieces. SAM ownership filings — Boston Beer remains tightly held, and any new amendment from Jim Koch, Vanguard, or AQR would matter more for SAM than anything in this COCO Form 4. ## FAQ ### Is Martin Roper still Boston Beer's CEO? No. Martin Roper was Boston Beer's CEO from 2001 to 2018. He is currently the chief executive officer of Vita Coco, while Boston Beer said in August 2025 that founder Jim Koch returned to the CEO role. ### Did this Form 4 show a full exit from Vita Coco? No. The filing showed 298,484 common shares after the April 8 sale in Form 4 Table I, and 529,670 derivative securities remaining in Table II after the exercise activity. ### Why does Martin Roper still show up as a Boston Beer insider on 13F Insight? Because most of his 2,955 historical insider transactions were tied to Boston Beer. His long SAM history still dominates the profile even though this April 2026 filing is a Vita Coco transaction. ### Why does the April 2026 exercise-and-sell matter? Roper sold into a strong post-earnings setup after Vita Coco reported 18% full-year sales growth, guided to another year of double-digit revenue expansion, and saw COCO reach a 52-week high in March. --- Source: 13F Insight — https://13finsight.com/news/martin-roper-boston-beer-ceo-vita-coco-exercise-sell-2026 Author: Alex Rivera — https://13finsight.com/authors/alex-rivera Last updated: 2026-04-14T00:11:44.325Z